Sichuan Hebang Biotechnology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Xiaoping Zeng
Chief executive officer
CN¥2.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Earnings Not Telling The Story For Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077)
Dec 18
Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?
Nov 19Returns On Capital At Sichuan Hebang Biotechnology (SHSE:603077) Have Stalled
Sep 25Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Shares Not Telling The Full Story
Aug 16Return Trends At Sichuan Hebang Biotechnology (SHSE:603077) Aren't Appealing
Jun 04Investors Holding Back On Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077)
May 13Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?
Mar 07Here's Why I Think Sichuan Hebang Biotechnology (SHSE:603077) Is An Interesting Stock
Apr 21CEO
Xiaoping Zeng (63 yo)
1.6yrs
Tenure
CN¥2,619,400
Compensation
Mr. Xiaoping Zeng is Chairman & GM of Sichuan Hebang Biotechnology Corporation Limited from March 15, 2023. Mr. Zeng was Chairman of Sichuan Hebang Biotechnology Corporation Limited from May 24, 2017. Mr....
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 8.6yrs | CN¥2.62m | no data | |
| CFO & Director | 16.8yrs | CN¥1.67m | 0.037% CN¥ 6.5m | |
| Independent Director | 4.6yrs | no data | no data | |
| Director | 16.8yrs | CN¥2.62m | 5.14% CN¥ 907.8m | |
| Independent Director | 4.6yrs | CN¥200.00k | no data | |
| Director | 3.6yrs | CN¥200.00k | 0.000050% CN¥ 8.8k | |
| Independent Director | 4.6yrs | CN¥200.00k | no data | |
| Employee Representative Supervisor | 7.6yrs | no data | no data | |
| Director | 1.6yrs | CN¥1.10m | no data | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Independent Director | 1.6yrs | CN¥200.00k | no data | |
| Director | 1.6yrs | CN¥707.80k | no data |
4.6yrs
Average Tenure
50yo
Average Age
Experienced Board: 603077's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 18:57 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sichuan Hebang Biotechnology Corporation Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Liu | Haitong International Research Limited |
| Turong Mai | Shenwan Hongyuan Securities |